Overlap between systemic lupus erythematosus and rheumatoid arthritis: Is it real or just an illusion?

Journal of Rheumatology

Volumn 36, Issue 1, 2009, Pages 4-6

  Amezcua Guerra, Luis M ^a  

^a UNIVERSIDAD LA SALLE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

AUTOIMMUNE DISEASE; EDITORIAL; FINGER MALFORMATION; HUMAN; LEUKOPENIA; MIXED CONNECTIVE TISSUE DISEASE; MORTALITY; MOUTH ULCER; PERICARDITIS; PHOTOSENSITIVITY; PLEURISY; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; PSORIATIC ARTHRITIS; PSYCHOSIS; RASH; REITER SYNDROME; RHEUMATIC FEVER; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THUMB MALFORMATION;

ARTHRITIS, RHEUMATOID; COMORBIDITY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 58149517602     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.081067     Document Type: Editorial

References (20)

1. Icen M, Nicola PJ, Maradit-Kremers H, et al. Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality. J Rheumatol 2009;36:50-7.
2. Cohen MG, Webb J. Concurrence of rheumatoid arthritis and systemic lupus erythematosus: report of 11 cases. Ann Rheum Dis 1987;46:853-8.
3. Panush RS, Edwards NL, Longley S, Webster E. "Rhupus" syndrome. Arch Intern Med 1988;148:1633-6.
4. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
5. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
6. Alarcon-Segovia D, Abud-Mendoza C, Diaz-Jouanen E, Iglesias A, De los Reyes V, Hernández-Ortiz J. Deforming arthropathy of the hands in systemic lupus erythematosus. J Rheumatol 1988;15:65-9.
7. van Vugt RM, Derksen RH, Kater L, Bijlsma JW. Deforming arthropathy or lupus and rhupus hands in systemic lupus erythematosus. Ann Rheum Dis 1998;57:540-4.
8. Toone EC Jr, Irby R, Pierce EL. The LE cell in rheumatoid arthritis. Am J Med Sci 1960;240:599-608.
9. Richter Cohen M, Steiner G, Smolen JS, Isenberg DA. Erosive arthritis in systemic lupus erythematosus: analysis of a distinct clinical and serological subset. Br J Rheumatol 1998;37:421-4.
10. Mediwake R, Isenberg DA, Schellekens GA, van Venrooij WJ. Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 2001;60:67-8.
11. Molberg O, Sollid LM. A gut feeling for joint inflammation - using coeliac disease to understand rheumatoid arthritis. Trends Immunol 2006;27:188-94.
12. Amezcua-Guerra LM, Springall R, Marquez-Velasco R, Gómez- García L, Vargas A, Bojalil R. Presence of antibodies against cyclic citrullinated peptides in patients with "rhupus": a cross-sectional study. Arthritis Res Ther 2006;8:R144.
13. Chan MT, Owen P, Dunphy J, et al. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. J Rheumatol 2008;35:77-83.
14. Martinez JB, Valero JS, Bautista AJ, et al. Erosive arthropathy: clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literature. Clin Exp Rheumatol 2007;25:47-53.
15. Damian-Abrego GN, Cabiedes J, Cabral AR. Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy. Lupus 2008;17:300-4.
16. Amezcua-Guerra LM, Marquez-Velasco R, Bojalil R. Erosive arthritis in systemic lupus erythematosus is associated with high serum C-reactive protein and anti-cyclic citrullinated peptide antibodies. Inflamm Res; (in press).
17. du Montcel ST, Michou L, Petit-Teixeira E, et al. New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility. Arthritis Rheum 2005;52:1063-8.
18. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006;54:1117-21.
19. Korendowych E, Owen P, Ravindran J, Carmichael C, McHugh N. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. Rheumatology Oxford 2005;44:1056-60.
20. Alarcon-Segovia D. Shared autoimmunity: a concept for which the time has come. Autoimmunity 2005;38:201-3.